BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 35001185)

  • 1. Endometrial hyperplasia as a risk factor of endometrial cancer.
    Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
    Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
    Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
    Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of endometrium hyperplasia and screening of endometrial intraepithelial neoplasia in histopathological images using a global-to-local multi-scale convolutional neural network.
    Zhao F; Dong D; Du H; Guo Y; Su X; Wang Z; Xie X; Wang M; Zhang H; Cao X; He X
    Comput Methods Programs Biomed; 2022 Jun; 221():106906. PubMed ID: 35671602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review.
    Murakami I; Machida H; Morisada T; Terao Y; Tabata T; Mikami M; Hirashima Y; Kobayashi Y; Baba T; Nagase S
    J Gynecol Oncol; 2023 Jul; 34(4):e49. PubMed ID: 36929578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Viggiani M; Giampaolino P; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 Jun; 299(6):1511-1524. PubMed ID: 30915635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
    Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
    Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.
    Obstet Gynecol; 2023 Sep; 142(3):735-744. PubMed ID: 37590985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
    Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
    APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.
    Li M; Song JL; Zhao Y; Wu SL; Liu HB; Tang R; Yan L
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):1022-1025. PubMed ID: 29119739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
    Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
    Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women.
    Uccella S; Zorzato PC; Dababou S; Bosco M; Torella M; Braga A; Frigerio M; Gardella B; Cianci S; Laganà AS; Franchi MP; Garzon S
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options for management of endometrial hyperplasia.
    Chandra V; Kim JJ; Benbrook DM; Dwivedi A; Rai R
    J Gynecol Oncol; 2016 Jan; 27(1):e8. PubMed ID: 26463434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endometrial cancer risk in patients with endometrial precancerous lesions: WHO 1994 vs EIN classification.
    Kender Erturk N; Basaran D; Salman C
    J Obstet Gynaecol; 2022 May; 42(4):692-695. PubMed ID: 34415826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis.
    Shao F; Li Y; Zhao Y
    Front Endocrinol (Lausanne); 2023; 14():1139858. PubMed ID: 37415671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.